Related Experiment Video
Updated: Sep 27, 2026

Transcranial Direct Current Stimulation for Online Gamers
Published on: November 9, 2019
Preliminary Outcomes of a Five-Session Motivation-Centered Program for Internet Gaming Disorder: A Completer Analysis
Ruoyu Zhou1, Nobuaki Morita2, Yasukazu Ogai2
1School of Future Education, Qingdao Hengxing University of Science and Technology, Qingdao 266100, China.
Abstract:
Brief campus-based interventions for university students with elevated internet gaming disorder (IGD) symptoms have received little study. This randomized trial evaluated a five-session group program focused on gaming motives, self-regulation, and alternative sources of competence and self-worth. Sixty-three adult students at a Chinese vocational college who scored at least 20 on an adapted Gaming Disorder Scale for Adolescents were randomized to the program (n = 31) or an information-only control condition (n = 32). Assessments were scheduled at baseline, immediately after the intervention, and one month later. Because post-randomization outcome data were unavailable for 19 participants, the comparative analyses were restricted to 44 completers. The originally planned baseline-adjusted ANCOVA showed a lower adjusted T1 IGD score in the intervention group than in the control group (adjusted difference = -4.62, 95% CI -7.33 to -1.91, p = 0.0013). In a post hoc linear mixed-effects model, the between-group difference in change from baseline to post-intervention was -5.16 points (95% CI -7.81 to -2.51; Hedges g = -1.03). At one month, the difference was smaller and not statistically significant (-1.67 points, 95% CI -4.31 to 0.98). None of the secondary outcomes showed a significant interaction. Overall attrition was 30.2%. These preliminary findings concern selected completers rather than an intention-to-treat effect, and the between-group difference was not evident at one month. Retrospective registration, unavailable outcomes for non-completers, and post hoc analyses limit the strength of the inference. The trial was retrospectively registered in UMIN-CTR (UMIN000055209) on 9 August 2024.
